Table: Mochida Pharm -2017/18 group results

Mochida Pharmaceutical

14/05/2018 06:00

May 14 (Reuters)- 
          Mochida Pharmaceutical Co Ltd 
          CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended      Year ended       Year to       NEXT   
              Mar 31, 2018    Mar 31, 2017   Mar 31, 2019     YEAR     
                 LATEST         YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS       FORECAST    H1 FORECAST 
  Sales          106.76           97.35         110.00                 
               (+9.7 pct)      (+5.5 pct)     (+3.0 pct)               
  Operating       11.66           11.37           7.00                 
               (+2.5 pct)      (-6.4 pct)     (-40.0 pct)              
  Recurring       12.01           11.65           7.30                 
               (+3.1 pct)      (-6.0 pct)     (-39.2 pct)              
  Net
  Net              9.02            8.53           6.40                 
               (+5.8 pct)      (+4.6 pct)     (-29.1 pct)              
  EPS          454.55 yen      429.46 yen     322.39 yen               
  Ann Div      170.00 yen      155.00 yen     160.00 yen               
  -Q2 Div       72.50 yen       55.00 yen      80.00 yen               
  -Q4 Div       97.50 yen      100.00 yen      80.00 yen               
  
  NOTE - Mochida Pharmaceutical Co Ltd.
  *Second Net profit row denotes profit attributable to owners ofthe parent 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4534.T